Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Medeon Biodesign, Inc. (6499.TWO)
Taipei, TW
Medeon Biodesign, Inc. engages in the research and development, manufacturing, and sale of medical devices in the United States. The company focuses on developing devices for minimally invasive surgeries, such as Cross-Seal, a large bore vascular closure system; Urocross, an expander system for treating lower urinary tract symptoms associated with benign prostatic hyperplasia; Duett, a vascular graft system; PUMA, solution to treat orthopedic extremity injuries; ClickClean, a solution to view throughout laparoscopic surgeries; and AbClose to prevent port site herniation caused by improper closure. It is engaged in the medical device contract manufacturing; and manufacture and sale of injection molding and components of medical devices. Medeon Biodesign, Inc. was incorporated in 2012 and is based in Taipei, Taiwan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.37% | -0.97% | -6.08% | -14.35% | -16.87% | -13.44% | +19.42% | +46.31% | +139.67% | -16.67% | -11.50% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Consumer Electronics: +7.8%+43.2% ★ Q1'26: +12.2% (vs Q1'25)
-
EPS growth Consumer Electronics: +23.0%+17.2% Q1'26: +34.7% (vs Q1'25)
-
FCF margin FCF growth · Consumer Electronics: +37.3%-179.3% Q1'26: -121.5% (vs Q1'25)
-
EBIT margin Consumer Electronics: +5.7%-172.3% Q1'26: -114.9% (vs Q1'25)
-
ROIC Consumer Electronics: +4.9%-168.0% Q1'26: -122.2% (vs Q1'25)
-
Share dilution Consumer Electronics: +0.0%+0.1% Q1'26: +4.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Consumer Electronics: -0.57×-0.16× Q1'26: -0.22× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.26B
est.
|
453.76M
est: 1.26B (-63.9%)
|
123.06M
est: 672.00M (-81.7%)
|
68.96M
est: 66.00M (+4.5%)
|
298.32M
est: 368.00M (-18.9%)
|
196.26M
est: 240.00M (-18.2%)
|
292.81M
est: 292.81M (+0.0%)
|
419.43M
est: 419.00M (+0.1%)
|
478.50M
478.50M – 478.50M
+14.2% YoY
|
1.75B
1.75B – 1.75B
+265.7% YoY
|
| EBITDA |
-1.26B
est.
|
-172.08M
est: -1.26B (+86.3%)
|
-256.46M
est: -672.00M (+61.8%)
|
-453.87M
est: -66.00M (-587.7%)
|
-370.10M
est: -368.00M (-0.6%)
|
-1.14B
est: -240.00M (-375.8%)
|
-754.43M
est: -292.81M (-157.7%)
|
-722.51M
est: -419.00M (-72.4%)
|
-478.50M
-478.50M – -478.50M
-14.2% YoY
|
-1.75B
-1.75B – -1.75B
-265.7% YoY
|
| EBIT |
-1.26B
est.
|
-251.33M
est: -1.26B (+80.0%)
|
-340.73M
est: -672.00M (+49.3%)
|
-512.88M
est: -66.00M (-677.1%)
|
-433.90M
est: -368.00M (-17.9%)
|
-1.24B
est: -240.00M (-415.7%)
|
-853.09M
est: -292.81M (-191.3%)
|
-722.51M
est: -419.00M (-72.4%)
|
-478.50M
-478.50M – -478.50M
-14.2% YoY
|
-1.75B
-1.75B – -1.75B
-265.7% YoY
|
| Net Income |
-247.23M
est.
|
-261.99M
est: 1.01B (-126.1%)
|
-192.74M
est: -154.13M (-25.0%)
|
2.08B
est: 2.06B (+0.9%)
|
-433.76M
est: -252.14M (-72.0%)
|
-1.20B
est: -1.07B (-12.7%)
|
-805.51M
est: -428.16M (-88.1%)
|
-719.34M
est: -668.06M (-7.7%)
|
-654.22M
-654.22M – -654.22M
+2.1% YoY
|
272.21M
272.21M – 272.21M
+141.6% YoY
|
| SGA |
1.14B
est.
|
141.99M
est: 1.14B (-87.5%)
|
98.50M
est: 608.53M (-83.8%)
|
108.35M
est: 59.77M (+81.3%)
|
153.03M
est: 333.25M (-54.1%)
|
185.91M
est: 217.33M (-14.5%)
|
203.75M
est: 265.15M (-23.2%)
|
—
est: 312.35M (-100.0%)
|
356.70M
356.70M – 356.70M
+14.2% YoY
|
1.30B
1.30B – 1.30B
+265.7% YoY
|
| EPS |
-2.68
est.
|
-2.86
est: 10.91 (-126.2%)
|
-2.10
est: -1.67 (-25.6%)
|
22.65
est: 22.35 (+1.3%)
|
-4.71
est: -2.73 (-72.2%)
|
-13.09
est: -11.60 (-12.9%)
|
-8.74
est: -4.64 (-88.2%)
|
-7.24
est: -7.24 (+0.0%)
|
-7.09
-7.09 – -7.09
+2.1% YoY
|
2.95
2.95 – 2.95
+141.6% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Yue-Teh Jang | Chairman of the Board & GM | 678.3K | — |
| Albert Weng | VP of Products Development | — | male |
| Greta Chang | Executive Vice President | — | female |
| Jenny Chen | Vice President of Finance & Business Analysis, Head of Corporate Governance and Chief Financial Officer | — | — |
| Tori Lin | Senior Manager of Finance & Business Analysis and Accounting Officer | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 6499.TWO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
